Cargando…
Use of a new proximity assay (NanoBRET) to investigate the ligand‐binding characteristics of three fluorescent ligands to the human β (1)‐adrenoceptor expressed in HEK‐293 cells
Previous research has indicated that allosteric interactions across the dimer interface of β (1)‐adrenoceptors may be responsible for a secondary low affinity binding conformation. Here we have investigated the potential for probe dependence, in the determination of antagonist pK(i) values at the hu...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4988514/ https://www.ncbi.nlm.nih.gov/pubmed/27588207 http://dx.doi.org/10.1002/prp2.250 |
_version_ | 1782448443122253824 |
---|---|
author | Soave, Mark Stoddart, Leigh A. Brown, Alastair Woolard, Jeanette Hill, Stephen J. |
author_facet | Soave, Mark Stoddart, Leigh A. Brown, Alastair Woolard, Jeanette Hill, Stephen J. |
author_sort | Soave, Mark |
collection | PubMed |
description | Previous research has indicated that allosteric interactions across the dimer interface of β (1)‐adrenoceptors may be responsible for a secondary low affinity binding conformation. Here we have investigated the potential for probe dependence, in the determination of antagonist pK(i) values at the human β (1)‐adenoceptor, which may result from such allosterism interactions. Three fluorescent β (1)‐adrenoceptor ligands were used to investigate this using bioluminescence energy transfer (BRET) between the receptor‐bound fluorescent ligand and the N‐terminal NanoLuc tag of a human β (1)‐adrenoceptor expressed in HEK 293 cells (NanoBRET). This proximity assay showed high‐affinity‐specific binding to the NanoLuc‐ β (1)‐adrenoceptor with each of the three fluorescent ligands yielding K (D) values of 87.1 ± 10 nmol/L (n = 8), 38.1 ± 12 nmol/L (n = 7), 13.4 ± 2 nmol/L (n = 14) for propranolol‐Peg8‐BY630, propranolol‐ β(Ala‐Ala)‐BY630 and CGP‐12177‐TMR, respectively. Parallel radioligand‐binding studies with (3)H‐CGP12177 and TIRF microscopy, to monitor NanoLuc bioluminescence, confirmed a high cell surface expression of the NanoLuc‐ β (1)‐adrenoceptor in HEK 293 cells (circa 1500 fmol.mg protein(−1)). Following a 1 h incubation with fluorescent ligands and β (1)‐adrenoceptor competing antagonists, there were significant differences (P < 0.001) in the pK(i) values obtained for CGP20712a and CGP 12177 with the different fluorescent ligands and (3)H‐CGP 12177. However, increasing the incubation time to 2 h removed these significant differences. The data obtained show that the NanoBRET assay can be applied successfully to study ligand‐receptor interactions at the human β (1)‐adrenoceptor. However, the study also emphasizes the importance of ensuring that both the fluorescent and competing ligands are in true equilibrium before interpretations regarding probe dependence can be made. |
format | Online Article Text |
id | pubmed-4988514 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-49885142016-08-30 Use of a new proximity assay (NanoBRET) to investigate the ligand‐binding characteristics of three fluorescent ligands to the human β (1)‐adrenoceptor expressed in HEK‐293 cells Soave, Mark Stoddart, Leigh A. Brown, Alastair Woolard, Jeanette Hill, Stephen J. Pharmacol Res Perspect Original Articles Previous research has indicated that allosteric interactions across the dimer interface of β (1)‐adrenoceptors may be responsible for a secondary low affinity binding conformation. Here we have investigated the potential for probe dependence, in the determination of antagonist pK(i) values at the human β (1)‐adenoceptor, which may result from such allosterism interactions. Three fluorescent β (1)‐adrenoceptor ligands were used to investigate this using bioluminescence energy transfer (BRET) between the receptor‐bound fluorescent ligand and the N‐terminal NanoLuc tag of a human β (1)‐adrenoceptor expressed in HEK 293 cells (NanoBRET). This proximity assay showed high‐affinity‐specific binding to the NanoLuc‐ β (1)‐adrenoceptor with each of the three fluorescent ligands yielding K (D) values of 87.1 ± 10 nmol/L (n = 8), 38.1 ± 12 nmol/L (n = 7), 13.4 ± 2 nmol/L (n = 14) for propranolol‐Peg8‐BY630, propranolol‐ β(Ala‐Ala)‐BY630 and CGP‐12177‐TMR, respectively. Parallel radioligand‐binding studies with (3)H‐CGP12177 and TIRF microscopy, to monitor NanoLuc bioluminescence, confirmed a high cell surface expression of the NanoLuc‐ β (1)‐adrenoceptor in HEK 293 cells (circa 1500 fmol.mg protein(−1)). Following a 1 h incubation with fluorescent ligands and β (1)‐adrenoceptor competing antagonists, there were significant differences (P < 0.001) in the pK(i) values obtained for CGP20712a and CGP 12177 with the different fluorescent ligands and (3)H‐CGP 12177. However, increasing the incubation time to 2 h removed these significant differences. The data obtained show that the NanoBRET assay can be applied successfully to study ligand‐receptor interactions at the human β (1)‐adrenoceptor. However, the study also emphasizes the importance of ensuring that both the fluorescent and competing ligands are in true equilibrium before interpretations regarding probe dependence can be made. John Wiley and Sons Inc. 2016-08-08 /pmc/articles/PMC4988514/ /pubmed/27588207 http://dx.doi.org/10.1002/prp2.250 Text en © 2016 The Authors. Pharmacology Research & Perspectives published by John Wiley & Sons Ltd, British Pharmacological Society and American Society for Pharmacology and Experimental Therapeutics. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Soave, Mark Stoddart, Leigh A. Brown, Alastair Woolard, Jeanette Hill, Stephen J. Use of a new proximity assay (NanoBRET) to investigate the ligand‐binding characteristics of three fluorescent ligands to the human β (1)‐adrenoceptor expressed in HEK‐293 cells |
title | Use of a new proximity assay (NanoBRET) to investigate the ligand‐binding characteristics of three fluorescent ligands to the human β
(1)‐adrenoceptor expressed in HEK‐293 cells |
title_full | Use of a new proximity assay (NanoBRET) to investigate the ligand‐binding characteristics of three fluorescent ligands to the human β
(1)‐adrenoceptor expressed in HEK‐293 cells |
title_fullStr | Use of a new proximity assay (NanoBRET) to investigate the ligand‐binding characteristics of three fluorescent ligands to the human β
(1)‐adrenoceptor expressed in HEK‐293 cells |
title_full_unstemmed | Use of a new proximity assay (NanoBRET) to investigate the ligand‐binding characteristics of three fluorescent ligands to the human β
(1)‐adrenoceptor expressed in HEK‐293 cells |
title_short | Use of a new proximity assay (NanoBRET) to investigate the ligand‐binding characteristics of three fluorescent ligands to the human β
(1)‐adrenoceptor expressed in HEK‐293 cells |
title_sort | use of a new proximity assay (nanobret) to investigate the ligand‐binding characteristics of three fluorescent ligands to the human β
(1)‐adrenoceptor expressed in hek‐293 cells |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4988514/ https://www.ncbi.nlm.nih.gov/pubmed/27588207 http://dx.doi.org/10.1002/prp2.250 |
work_keys_str_mv | AT soavemark useofanewproximityassaynanobrettoinvestigatetheligandbindingcharacteristicsofthreefluorescentligandstothehumanb1adrenoceptorexpressedinhek293cells AT stoddartleigha useofanewproximityassaynanobrettoinvestigatetheligandbindingcharacteristicsofthreefluorescentligandstothehumanb1adrenoceptorexpressedinhek293cells AT brownalastair useofanewproximityassaynanobrettoinvestigatetheligandbindingcharacteristicsofthreefluorescentligandstothehumanb1adrenoceptorexpressedinhek293cells AT woolardjeanette useofanewproximityassaynanobrettoinvestigatetheligandbindingcharacteristicsofthreefluorescentligandstothehumanb1adrenoceptorexpressedinhek293cells AT hillstephenj useofanewproximityassaynanobrettoinvestigatetheligandbindingcharacteristicsofthreefluorescentligandstothehumanb1adrenoceptorexpressedinhek293cells |